Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04693052 · ClinicalTrials.gov registry record
Attitudes Towards Receiving Mental Health Care Using Telehealth During the Coronavirus Disease 2019 (COVID-19) Pandemic
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 605
- Enrollment target
NCT04693052: Completed study, sponsored by Northwestern University.
NCT04693052 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 605 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04693052 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 605 participants
- Enrollment target
Study Summary
The purpose of this study is to collect patients' experiences and feedback to better understand and improve mental health care using telehealth services. This is critically important as telehealth appointments, including both phone and video calls, continue to be offered for regular appointments to reduce in-person interaction as a preventive measure to help control the spread of COVID-19.
Primary Outcome
Patients choosing telehealth or not for future case, or unsure)
Interventions
- OTHER No interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 605 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2021-01-31 |
What the finished NCT04693052 record still lists
NCT04693052 is an observational study that tracks outcomes without assigning an intervention. The registered 605 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No interventions is the first listed.
NCT04693052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04693052 about?
NCT04693052 is a clinical study titled "Attitudes Towards Receiving Mental Health Care Using Telehealth During the Coronavirus Disease 2019 (COVID-19) Pandemic". The purpose of this study is to collect patients' experiences and feedback to better understand and improve mental health care using telehealth services. This is critically important as telehealth appointments, including both phone and video calls, continue to be offered for regular appointments to ...
What is the current status of trial NCT04693052?
This trial is currently completed. The enrollment target is 605 participants. The study started on 2020-12-10. Estimated completion is 2021-01-31.
What interventions are being tested in trial NCT04693052?
The interventions under investigation include: No interventions (OTHER).
Who is sponsoring clinical trial NCT04693052?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI